Podcasts about cme

  • 1,295PODCASTS
  • 13,942EPISODES
  • 41mAVG DURATION
  • 5DAILY NEW EPISODES
  • Jul 23, 2025LATEST

POPULARITY

20172018201920202021202220232024

Categories




Best podcasts about cme

Show all podcasts related to cme

Latest podcast episodes about cme

Business Breakdowns
CME Group: The House Always Wins - [Business Breakdowns, EP.224]

Business Breakdowns

Play Episode Listen Later Jul 23, 2025 60:23


 This is Matt Reustle and today we are breaking down the Chicago Mercantile Exchange. My guest is Adam Chandler, co-PM at Claremont Global, and together we get into the nitty gritty of exchanges. We all know how integral exchanges are to the financial system but we rarely stop to understand how they operate, how they make money, and how they shape the flow of dollars. This episode aims to do just that. Please enjoy this breakdown of the Chicago Mercantile Exchange. For the full show notes, transcript, and links to the best content to learn more, check out the episode page here⁠⁠⁠⁠⁠. —- Business Breakdowns is a property of Colossus, LLC. For more episodes of Business Breakdowns, visit⁠⁠⁠⁠⁠ joincolossus.com/episodes⁠⁠⁠⁠⁠. Editing and post-production work for this episode was provided by The Podcast Consultant (⁠⁠⁠⁠⁠https://thepodcastconsultant.com⁠⁠⁠⁠⁠). Show Notes (00:00:00) Introduction to Business Breakdowns (00:00:51) Introducing the Chicago Mercantile Exchange (00:01:52) Understanding the Exchange Business (00:03:38) The Role of Clearinghouses (00:04:29) Diving into CME's Specialization (00:07:18) Historical Evolution of CME (00:09:40) Modern Operations and Risk Management (00:19:39) CME's Market Position and Growth (00:29:13) Revenue Breakdown and Product Insights (00:35:23) Volume Drivers: Treasuries and Interest Rate Markets (00:36:47) Comparing CME with Other Exchanges (00:42:10) Profitability and Cost Structure of CME (00:45:37) Capital Allocation and Dividend Strategy (00:47:35) Innovation and New Product Offerings (00:49:24) Impact of Passive Investing on CME (00:53:09) Risks and Regulatory Environment (00:58:26) Key Lessons from CME's Business Model

Life's Best Medicine Podcast
Episode 259: Doug Reynolds | The Symposium for Metabolic Health – San Diego 2025

Life's Best Medicine Podcast

Play Episode Listen Later Jul 23, 2025 62:32


Thank you for tuning in for another episode of Life's Best Medicine. Doug Reynolds is the founder of LowCarbUSA®, a leading organization dedicated to promoting low-carb, ketogenic, and metabolic health through science-based education. A former endurance athlete and self-proclaimed “carb skeptic,” Doug turned his personal health journey into a mission to help others reclaim their lives through nutrition. One of his most impactful contributions to the fight for metabolic health is The LowCarbUSA® conference. Officially known as the Symposium for Metabolic Health, it is a premier scientific and clinical event hosted by LowCarbUSA® in collaboration with the Society of Metabolic Health Practitioners (SMHP). Founded by Doug in 2016, it brings together world‑renowned researchers, healthcare professionals, and passionate individuals to explore the therapeutic benefits of carbohydrate restriction—and its role in combating insulin resistance, inflammation, hyperinsulinemia, type 2 diabetes, obesity, cardiovascular and neurological disorders. The Symposium for Metabolic Health – San Diego 2025, hosted by LowCarbUSA® and the Society of Metabolic Health Practitioners (SMHP), takes place August 14–17 at the Loews Coronado Bay Resort. This premier event brings together healthcare professionals, researchers, and health enthusiasts to explore cutting-edge science and clinical strategies focused on therapeutic carbohydrate reduction and metabolic health. Highlights include a full day dedicated to brain and neurological health, 28 CME credits, practical tools for improving patient outcomes, and unique networking opportunities—all set against the scenic backdrop of Coronado Bay, with both in-person and livestream options available.   For more information, please see the links below. Thank you for listening!   Links:   Doug Reynolds: 2025 Symposium for Metabolic Health: https://thesmhp.org/symposium-for-metabolic-health-san-diego-2025/ LowCarbUSA: https://www.lowcarbusa.org X: https://x.com/dougiereynolds?lang=en PROMO CODE FOR EVENT (20% off): Low Carb MD   Dr. Brian Lenzkes:  Arizona Metabolic Health: https://arizonametabolichealth.com/ Low Carb MD Podcast: https://www.lowcarbmd.com/   HLTH Code: HLTH Code Promo Code: METHEALTH • • HLTH Code Website: https://gethlth.com

Life Coaching for Women Physicians
270: Invisible Weight - Impact of Emotional Inflammation on the Body

Life Coaching for Women Physicians

Play Episode Listen Later Jul 22, 2025 18:21


Episode Summary: The Invisible Weight of Emotional Exhaustion and BurnoutIn this week's episode, Dr. Ali Novitsky explores the profound impact of emotional exhaustion on both mental and physical health. Emotional stress, often overlooked, can lead to elevated cortisol levels, inflammation, and hindered weight loss. Despite these effects, many hesitate to take time off for emotional well-being.Emotional Stress & Physical HealthDr. Novitsky details how emotional stress triggers physiological changes—such as fluid retention and inflammation—that directly affect health outcomes. Elevated cortisol from stress is particularly impactful on metabolism and weight regulation.Research on Emotional Stress ResponsesDr. Novitsky introduces her current research involving 150 women in the Transform program. The study categorizes emotional stress types and applies targeted interventions to help participants better manage their emotional responses and reduce burnout.The High Achiever TrapHigh achievers often overextend themselves by prioritizing others. Dr. Novitsky shares personal stories of being caught in this cycle—over-delivering and sacrificing mental health. She emphasizes the critical need for boundaries to avoid emotional inflammation and burnout.Boundaries as Emotional ProtectionSetting boundaries is essential for mental health. Dr. Novitsky explains how saying “no,” even when it's difficult, can protect emotional space and prevent burnout. She encourages listeners to assess where they need to draw lines—with others and themselves.Mental & Emotional InflammationFast-paced thinking and chronic stress often result in what Dr. Novitsky calls “mental inflammation.” She discusses how emotions drive thoughts, leading to restlessness and burnout. Creating mental boundaries helps slow this cycle.Practical StrategiesListeners are urged to take an “inventory” of their emotional health and boundaries. Tools include:Identifying areas of emotional floodingSetting personal boundariesReducing commitments that cause strainRecognizing when the dopamine hit of “yes” becomes harmfulPrograms & ResourcesDr. Novitsky highlights several FIT Collective offerings:Transform Program (72 CME credits, enrolling January)CME Nutrition Training ProgramGenetics CohortBeginner Strength and Total Fitness programsMore information is available at thefitcollective.com.Closing MessageDr. Novitsky looks forward to sharing upcoming workshop data on emotional stress types and encourages listeners to prioritize emotional self-care. Protecting your space, she says, is not selfish—it's essential.

Hematologic Oncology Update
Chronic Lymphocytic Leukemia — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Hematologic Oncology Update

Play Episode Listen Later Jul 22, 2025 60:43


Dr Catherine Coombs and Dr William Wierda summarize major treatment advances in chronic lymphocytic leukemia presented at the 2025 American Society of Clinical Oncology Annual Meeting and review ongoing clinical trials. CME information and select publications here.

Anesthesia Patient Safety Podcast
#264 Rethinking Resuscitation in the Operating Room: Beyond ACLS

Anesthesia Patient Safety Podcast

Play Episode Listen Later Jul 22, 2025 16:13 Transcription Available


Cardiac arrest in the operating room presents unique challenges that standard Advanced Cardiovascular Life Support (ACLS) protocols simply were not designed to address. This eye-opening exploration with APSF author, Zachary Smith, reveals why traditional resuscitation guidelines fall short when emergencies strike during surgery and anesthesia care.The dynamics of cardiac arrest differ dramatically in the perioperative environment. While out-of-hospital arrests typically stem from arrhythmic events, OR emergencies often result from hemorrhage, embolism, hypoxemia, or critical drug reactions like malignant hyperthermia or local anesthetic toxicity. These scenarios demand immediate, specialized interventions beyond standard ACLS algorithms.Physical constraints further complicate matters. What happens when cardiac arrest occurs while a patient is positioned prone, lateral, or in steep Trendelenburg? Traditional compressions become impossible, and emerging research suggests prone CPR might actually be superior in some scenarios. Moreover, the advanced monitoring capabilities in the OR – arterial lines, central venous pressure readings, and echocardiography – provide critical data not incorporated into standard protocols.The American Society of Anesthesiologists has responded with their Perioperative Resuscitation and Life Support Certificate program, addressing these gaps through specialized training that combines ACLS principles with OR-specific knowledge.  Ready to enhance your skills beyond basic ACLS? Explore the ASA's certificate program to earn patient safety CME credits while gaining life-saving expertise tailored to the unique challenges of the operating room. Your specialized knowledge could make all the difference when seconds count.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/264-rethinking-resuscitation-in-the-operating-room-beyond-acls/© 2025, The Anesthesia Patient Safety Foundation

Low Carb MD Podcast
Shaping the Future of Metabolic Health: The 2025 San Diego Symposium | Doug Reynolds - E404

Low Carb MD Podcast

Play Episode Listen Later Jul 21, 2025 58:12


Doug Reynolds is the founder of LowCarbUSA®, a leading organization dedicated to promoting low-carb, ketogenic, and metabolic health through science-based education. A former endurance athlete and self-proclaimed “carb skeptic,” Doug turned his personal health journey into a mission to help others reclaim their lives through nutrition. One of his most impactful contributions to the fight for metabolic health is The LowCarbUSA® conference. Officially known as the Symposium for Metabolic Health, it is a premier scientific and clinical event hosted by LowCarbUSA® in collaboration with the Society of Metabolic Health Practitioners (SMHP). Founded by Doug in 2016, it brings together world‑renowned researchers, healthcare professionals, and passionate individuals to explore the therapeutic benefits of carbohydrate restriction—and its role in combating insulin resistance, inflammation, hyperinsulinemia, type 2 diabetes, obesity, cardiovascular and neurological disorders. The Symposium for Metabolic Health – San Diego 2025, hosted by LowCarbUSA® and the Society of Metabolic Health Practitioners (SMHP), takes place August 14–17 at the Loews Coronado Bay Resort. This premier event brings together healthcare professionals, researchers, and health enthusiasts to explore cutting-edge science and clinical strategies focused on therapeutic carbohydrate reduction and metabolic health. Highlights include a full day dedicated to brain and neurological health, 28 CME credits, practical tools for improving patient outcomes, and unique networking opportunities—all set against the scenic backdrop of Coronado Bay, with both in-person and livestream options available. In this episode, Dr. Tro, Dr. Brian and Doug talk about… (00:00) Intro (4:41) Metabolic psychiatry and ketogenic therapies for mental health conditions (13:58) Why it is ketosis and metabolic health that matters, not counting calories (20:17) GLP-1 drugs (22:25) The speaker line-up for the upcoming 2025 Symposium for Metabolic Health in San Diego, CA (42:42) Why you should come to the Symposium! (49:11) PROMO CODE FOR EVENT (20% off): Low Carb MD For more information, please see the links below. Thank you for listening!   Links:   Please consider supporting us on Patreon: https://www.lowcarbmd.com/   Doug Reynolds: 2025 Symposium for Metabolic Health: https://thesmhp.org/symposium-for-metabolic-health-san-diego-2025/ LowCarbUSA: https://www.lowcarbusa.org X: https://x.com/dougiereynolds?lang=en PROMO CODE FOR EVENT (20% off): Low Carb MD   Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author   Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro Instagram: https://www.instagram.com/doctortro/   Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.    Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/ 

EM Over Easy
RRC Updates Med Student over Easy

EM Over Easy

Play Episode Listen Later Jul 21, 2025 16:16


Listen as hosts Kaitlin Bowers and Molly Estes are joined by guest and host of EM Over Easy, Andy Little to discuss the proposed ACGME RRC Updates for emergency medicine. Don't forget our parent show EM Over Easy is the official podcast of the American College of Osteopathic Emergency Physicians. To learn more about this organization and how you can attend a future CME event, visit acoep.org today!

Research To Practice | Oncology Videos
Chronic Lymphocytic Leukemia — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Research To Practice | Oncology Videos

Play Episode Listen Later Jul 21, 2025 60:43


Featuring perspectives from Dr Catherine C Coombs and Dr William G Wierda, including the following topics: Introduction (0:00) Selection and Sequencing of Therapy for Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) — Dr Wierda (19:25) First-Line Therapy for CLL — Dr Coombs (44:18) Novel Agents and Strategies for R/R CLL — Dr Wierda (57:27) CME information and select publications

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast
Shervin Assassi, MD, MS - The Evolving Landscape of Fibrosing Interstitial Lung Diseases: Equipping Clinicians to Enhance Patient Care in the Era of Antifibrotic Therapy

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast

Play Episode Listen Later Jul 21, 2025 58:20


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XMG865. CME credit will be available until July 9, 2026.The Evolving Landscape of Fibrosing Interstitial Lung Diseases: Equipping Clinicians to Enhance Patient Care in the Era of Antifibrotic Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
Pier Luigi Zinzani, MD, PhD - Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Play Episode Listen Later Jul 21, 2025 77:18


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZE865. CME credit will be available until July 22, 2026.Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
Shervin Assassi, MD, MS - The Evolving Landscape of Fibrosing Interstitial Lung Diseases: Equipping Clinicians to Enhance Patient Care in the Era of Antifibrotic Therapy

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Play Episode Listen Later Jul 21, 2025 58:20


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XMG865. CME credit will be available until July 9, 2026.The Evolving Landscape of Fibrosing Interstitial Lung Diseases: Equipping Clinicians to Enhance Patient Care in the Era of Antifibrotic Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
Pier Luigi Zinzani, MD, PhD - Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

Play Episode Listen Later Jul 21, 2025 77:18


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZE865. CME credit will be available until July 22, 2026.Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Internal Medicine CME/CNE/CPE Video Podcast
Pier Luigi Zinzani, MD, PhD - Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations

PeerView Internal Medicine CME/CNE/CPE Video Podcast

Play Episode Listen Later Jul 21, 2025 77:18


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZE865. CME credit will be available until July 22, 2026.Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Internal Medicine CME/CNE/CPE Audio Podcast
Pier Luigi Zinzani, MD, PhD - Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations

PeerView Internal Medicine CME/CNE/CPE Audio Podcast

Play Episode Listen Later Jul 21, 2025 77:18


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZE865. CME credit will be available until July 22, 2026.Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
Pier Luigi Zinzani, MD, PhD - Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

Play Episode Listen Later Jul 21, 2025 77:18


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZE865. CME credit will be available until July 22, 2026.Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast
Shervin Assassi, MD, MS - The Evolving Landscape of Fibrosing Interstitial Lung Diseases: Equipping Clinicians to Enhance Patient Care in the Era of Antifibrotic Therapy

PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast

Play Episode Listen Later Jul 21, 2025 58:20


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XMG865. CME credit will be available until July 9, 2026.The Evolving Landscape of Fibrosing Interstitial Lung Diseases: Equipping Clinicians to Enhance Patient Care in the Era of Antifibrotic Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

PeerView Clinical Pharmacology CME/CNE/CPE Video
Pier Luigi Zinzani, MD, PhD - Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations

PeerView Clinical Pharmacology CME/CNE/CPE Video

Play Episode Listen Later Jul 21, 2025 77:18


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZE865. CME credit will be available until July 22, 2026.Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Clinical Pharmacology CME/CNE/CPE Video
Shervin Assassi, MD, MS - The Evolving Landscape of Fibrosing Interstitial Lung Diseases: Equipping Clinicians to Enhance Patient Care in the Era of Antifibrotic Therapy

PeerView Clinical Pharmacology CME/CNE/CPE Video

Play Episode Listen Later Jul 21, 2025 58:20


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XMG865. CME credit will be available until July 9, 2026.The Evolving Landscape of Fibrosing Interstitial Lung Diseases: Equipping Clinicians to Enhance Patient Care in the Era of Antifibrotic Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

Practical EMS
111 | Michelle Niemeyer | Moving away from practicing law | Work life balance is bulls**t | Building community | Avoiding burnout | Getting clarity

Practical EMS

Play Episode Listen Later Jul 20, 2025 34:47


Creator of the philosophy The Art of Bending TimeYou can find her work at Michelleniemeyer.com, LinkedIn and can text CLARITY to 33777 to get supportMichelle talks about what moved her away from law to helping others improve their livesFinding fulfillment outside of work hours to pursue something that is important to you can have beneficial effects on your work hoursWork life balance is bullshit Sometimes building community and social interactions while at work is an important step to building a strong team. Telling your family and friends outside of work about your work life can be equally important. They don't have to be totally separate parts of youIn the end, we are whole peoplePersonally, it is easy for me to isolate at work, but I feel better when I make the intentional time to get to know my coworkersRemember your spouse is a partner in life with you, invite them into your work strugglesTake care of your body and your mind to avoid burnoutBe clear who you areTEXT CLARITY to 33777 to get access to a free community page with Michelle's guided meditation program to help you get clarity on life and remember what bring you passion and fulfilment in lifeCreating a roadmap in life is crucial to making the life you want happenSometimes very difficult things are obtainable, but you have to take one step at a timeMichelle speaks to some healthy habits she has daily to start her day the right way, like taking her dog for a walkHabits of unwinding at the end of the day are key as well, put down the phone well before bedLeave for work with some extra time built in so you don't get frustrated by traffic, start your day on a positive noteSupport the showFull show notes can be found here: Episodes - Practical EMS - Content for EMTs, PAs, ParamedicsMost efficient online EKG course here: Practical EKG Interpretation - Practical EMS earn 4 CME and learn the fundamentals through advanced EKG interpretation in under 4 hours. If you want to work on your nutrition, increase your energy, improve your physical and mental health, I highly recommend 1st Phorm. Check them out here so they know I sent you. 1st Phorm | The Foundation of High Performance Nutrition Everything you hear today from myself and my guests is opinion only and doesn't represent any organizations or companies that any of us are affiliated with. The stories you hear have been modified to protect patient privacy and any resemblance to real individuals is coincidental. This is for educational and entertainment purposes only and should not be taken as medical advice nor used to diagnose any medical or healthcare conditions.

Hematologic Oncology Update
Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Hematologic Oncology Update

Play Episode Listen Later Jul 18, 2025 58:41


Dr Ajay K Nooka from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss recent updates on available and novel treatment strategies for multiple myeloma. CME information and select publications here.

Market Trends with Tracy
Meltdown Mode

Market Trends with Tracy

Play Episode Listen Later Jul 18, 2025 3:30


BEEF: Beef is finally cooling off—but is it enough? Strip loins and ribeyes are leading the decline, but ground beef and roasts are holding firm. With production still lagging behind last year, could this be the start of a slow slide or just a summer stall?POULTRY: Chicken remains the go-to protein, but how long can it hold? Wings are flying high on demand, breasts and tenders are steady, and production is slightly up. No new Avian Flu reports this week, which is always good news.GRAINS: Soybeans are about to stir things up. Despite strong supply and a promising crop, new demand for biofuel could send prices climbing fast. Will corn and wheat follow suit? Stay tuned.PORK: Bellies keep marching higher, and there's no sign of slowing. While other cuts ease off recent highs, bacon's sizzling summer run looks far from over – will August bring the peak, or just more heat?DAIRY: Dairy takes a dip across the board this week – but is it the bottom, or just the beginning? With block, barrel, and butter all sliding, the market may have more room to melt.Savalfoods.com | Find us on Social Media: Instagram, Facebook, YouTube, Twitter, LinkedIn

Straight From The Cutter's Mouth: A Retina Podcast
: State of Retina in 2025 with ASRS President Dr. Michael Jumper

Straight From The Cutter's Mouth: A Retina Podcast

Play Episode Listen Later Jul 17, 2025


Current American Society of Retinal Specialists (ASRS) President Dr. Michael Jumper joins to discuss current issues facing retinal specialists in 2025, including focused practice designation, Good Days funding, operating room access, and practice consolidation. Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Connecting the Dots
Radical Listening with Christian van Nieuwerburgh and Robert Biswas-Diener

Connecting the Dots

Play Episode Listen Later Jul 17, 2025 32:11


Prof. Christian van Nieuwerburgh (PhD) is an academic, consultant and executive coach. He is Professor of Coaching and Positive Psychology at the Centre for Positive Health Sciences at RCSI University of Medicine and Health Sciences (Ireland) and Consulting Professor for Growth Coaching International, a provider of coach training and consultancy for the education sector. In recognition of his contributions to the fields of positive psychology and coaching, he is Principal Fellow of the Centre for Wellbeing Science at the Melbourne Graduate School of Education of the University of Melbourne (Australia) and Honorary CollectivEd Fellow of the Carnegie School of Education at Leeds Beckett University (UK). Christian is a certified executive coach and is well published in the academic literature on the topics of coaching and positive psychology. He has authored, co-authored and edited numerous books in the field of coaching, most notably An Introduction to Coaching Skills: A Practical Guide (2014, 2016, 2020). His latest books are Your Essential Guide to Effective Reflective Practice (2025, with David Love) and Radical Listening: The Art of True Connection (2025, with Robert Biswas-Diener). Follow Christian on Instagram (@coachonamotorcycle), on his YouTube channel (@coachonamotorcycle) and on his website (coachonamotorcycle.com). Dr. Robert Biswas-Diener is a psychologist who researches positive topics as wide-ranging as happiness, friendship, hospitality, and friendship. His studies have taken him to Greenland, India, and Kenya. Robert has published more than 75 academic papers and has a citation count in excess of 28 thousand. Robert is also interested in applying positive psychology, especially to coaching. He is an ICF-certified coach and a Gallup certified strengths coach, and he trains coaches at his company, Positive Acorn.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Research To Practice | Oncology Videos
Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Research To Practice | Oncology Videos

Play Episode Listen Later Jul 17, 2025 58:41


Featuring perspectives from Dr Ajay K Nooka and Dr Paul G Richardson, including the following topics: Introduction: ASCO 2025 Showstoppers (0:00) Up-Front Treatment of Multiple Myeloma (MM) — Survey Questions (5:50) Emerging Novel Therapies for Relapsed/Refractory (R/R) MM — Faculty Presentation (11:57) Emerging Novel Therapies for R/R MM — Survey Questions (26:19) Current Management of R/R MM — Faculty Presentation (38:34) Current Management of R/R MM — Survey Questions (49:20) CME information and select publications

AMA COVID-19 Update
Steps for leaving the medical profession: When and how to decide to stop practicing medicine

AMA COVID-19 Update

Play Episode Listen Later Jul 17, 2025 11:31


When should a doctor stop seeing patients? What are the alternative careers for doctors? Why do physicians leave practice? What other jobs can you get with an MD? Our guest is Debra Atkisson, MD, senior vice president of clinical services at Blended Health and a professional certified coach. In this episode, Dr. Atkisson talks about navigating the transition out of medical practice. American Medical Association CXO Todd Unger hosts.

Lung Cancer Update
Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates

Lung Cancer Update

Play Episode Listen Later Jul 17, 2025 88:41


Prof Marina Garassino, Dr John Heymach, Prof Solange Peters and moderator Dr Jacob Sands present key data from the ASCO 2025 Annual Meeting on the management of metastatic NSCLC without targetable mutations, as well as emerging evidence on the role of antibody-drug conjugates for patients with select actionable genomic alterations. CME information and select publications here.

Research To Practice | Oncology Videos
Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates

Research To Practice | Oncology Videos

Play Episode Listen Later Jul 16, 2025 88:42


Featuring perspectives from Prof Marina Chiara Garassino, Dr John V Heymach, Prof Solange Peters and Dr Jacob Sands, moderated by Dr Sands, including the following topics: Introduction (0:00) Role of Immune Checkpoint Inhibitors in Metastatic Non-Small Cell Lung Cancer (NSCLC) without a Targetable Tumor Mutation — Prof Peters (2:07) Targeted and Other Novel Therapeutic Strategies for Relapsed Metastatic NSCLC — Prof Garassino (26:30) Potential Role of TROP2-Targeted Antibody-Drug Conjugates in Advanced NSCLC — Dr Sands (50:19) Evolving Role of Immune Checkpoint Inhibitors in the Care of Patients with Nonmetastatic NSCLC — Dr Heymach (1:12:36) CME information and select publications

Continuum Audio
Management of Normal Pressure Hydrocephalus With Dr. Kaisorn Chaichana

Continuum Audio

Play Episode Listen Later Jul 16, 2025 17:47


Normal pressure hydrocephalus (NPH) is a pathologic condition whereby excess CSF is retained in and around the brain despite normal intracranial pressure. MRI-safe programmable shunt valves allow for fluid drainage adjustment based on patients' symptoms and radiographic images. Approximately 75% of patients with NPH improve after shunt surgery regardless of shunt type or location. In this episode, Aaron Berkowitz, MD, PhD, FAAN, speaks with Kaisorn L. Chaichana, MD, author of the article “Management of Normal Pressure Hydrocephalus” in the Continuum® June 2025 Disorders of CSF Dynamics issue. Dr. Berkowitz is a Continuum® Audio interviewer and a professor of neurology at the University of California San Francisco in the Department of Neurology in San Francisco, California. Dr. Chaichana is a professor of neurology in the department of neurological surgery at the Mayo Clinic in Jacksonville, Florida. Additional Resources Read the article: Management of Normal Pressure Hydrocephalus Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @LyellJ Guest: @kchaichanamd Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Berkowitz: This is Dr Aaron Berkowitz, and today I'm interviewing Dr Kaisorn Chaichana about his article on management of normal pressure hydrocephalus, which he wrote with Dr Jeremy Cutsforth-Gregory. The article appears in the June 2025 Continuum issue on disorders of CSF dynamics. Welcome to the podcast, and please introduce yourself to our audience. Dr Chaichana: Yeah, thank you for having me. I'm Kaisorn Chaichana. I'm a neurosurgeon at Mayo Clinic in Jacksonville, Florida. Part of my practice is doing hydrocephalus care, which includes shunts for patients with normal pressure hydrocephalus. Dr Berkowitz: Fantastic. Well, before we get into shunt considerations and NPH specifically, which I know is the focus of your article, I thought it would be a great opportunity for a neurologist to pick a neurosurgeon's brain a bit about shunts. So, to start, can you lay out for us the different types of shunts and shunt procedures, the advantages, disadvantages of each type of shunt, how you think about which shunt procedure should be used for which patient, that type of thing? Dr Chaichana: Yeah. So, there are different types of shunts, and the most common one that is used is called a ventricular peritoneal shunt. So, it has a ventricular catheter, it has a catheter that tunnels underneath the skin and it goes into the peritoneum where the fluid goes from the ventricular system into the peritoneum. Typically, the shunts are in the ventricle because that is the largest fluid-filled space in the brain. Other terminal areas include the atrium, which is really the jugular vein, and those are called ventricular atrial shunts. You can also have ventricular pleural shunts, which end in the pleural space and drain flui into the pleural space. Those are pretty much the most common ventricular shunts. There's also a lumboperitoneal shunt that drains from the lumbar spine, similar to a lumbar drain into the peritoneum. For the lumbar shunts, we don't typically have a lumbar pleural or lumbar atrial shunt just because of the pressure dynamics, because the lumbar spine is below the lung and as well as the atrium. And so, the drainage pattern is very different than ventricular peritoneal which is top to bottom. The most common shunt, why we use the ventricular peritoneal shunt the most, is because it has the most control. So, the peritoneum is set at a standard pressure in the intraabdominal pressure, whereas the ventricular atrial shunt depends on your venous return or venous pressure and your ventricular pleural shunt varies with inspiration and expiration. So, the easiest way for us to control the fluid, the ventricular system is through the ventricular peritoneal shunt. And that's why that's our most common shunt that we use. Dr Berkowitz: Fantastic. So, as you mention in the article, neurologists may be reluctant to offer a shunt to patients with NPH because many patients may not improve, or they improve only transiently; and out of fear of shunt complications. So, of course, as neurologists, we often only hear about a patient's shunt when there is a problem. So, we have this sort of biased view of seeing a lot of shunt malfunction and shunt infection. Of course, we might not see the patient if their shunt is working just fine. How common are these complications in practice, and how do you as a neurosurgeon weigh the risks against the often uncertain or transient benefits of a shunt in a patient with NPH who may be older and multiple medical comorbidities? How do you think about that and talk about it with patients? Dr Chaichana: When you hear about shunt complications, most of the shunt complications you hear about are typically in patients with congenital hydrocephalus. Those patients often require several shunt revisions just from either growing or the shunt stays in for a long time or the ventricular caliber is a lot less than some with normal pressure hydrocephalus. So, we don't really see a lot of complications with normal pressure hydrocephalus. So that shunt placement in these patients is typically pretty safe. The procedure's a relatively short procedure, around 30 minutes to 45 minutes to place a shunt, and we can control the pressure within the shunt setting so that we don't overdrain---which means too much fluid drains from the ventricular system---which can cause things like a subdural, which is probably the most common complication associated with normal pressure hydrocephalus. So, to obviate those risks, what we do is typically insert the shunt and then keep the shunt setting at a high setting. The higher the setting, the less it drains, and then we bring it slowly down based on the patient's symptoms to try to minimize the risk of this over drainage in the subdural hematoma while at the same time benefiting the patient. So, there's a concern for shunt in patients with normal pressure hydrocephalus. The concern or the complication risks are very low. The problem with normal pressure hydrocephalus, though, is that over time these patients benefit less and less from drainage or their disease process takes over. So, I do recommend placing this shunt as soon as possible just so that we can maximize their quality of life for that period of time. Dr Berkowitz: So, if I'm understanding you, then the risk of complication is more sort of due to the mechanical factors in patients with congenital hydrocephalus or sort of outgrowing the shunt, their pressure dynamics may be changing over time. And in your experience, an older patient with NPH, although they may have more medical comorbidities, the procedure itself is relatively quick and low-risk. And the actual complications due to mechanical factors, my understanding, are just much less common because the patient is obviously fully grown and they're getting one sort of procedure at one point in time and tend to need less revision, have less complication. Is that right? Dr Chaichana: Yeah, that's correct. The complication risk for normal hydrocephalus is a lot less than other types of hydrocephalus. Dr Berkowitz: That's helpful to know. While we're talking about some of these complications, let's say we're following a patient in neurology with NPH who has a shunt. What are some of the symptoms and signs of shunt malfunction or shunt infection? And what are the best studies to order to evaluate for these if we're concerned about them? Dr Chaichana: Yeah. So basically, for shunt malfunction, it's basically broken down into two categories. It's either overdrainage or underdrainage. So, underdrainage is where the shunt doesn't function enough. And so basically, they return to their state before the shunt was placed. So that could be worsening gait function, memory function, urinary incontinence are the typical symptoms we look for in patients with normal pressure hydrocephalus and underdrainage, or the shunt is not working. For patients that are having overdrainage, which is draining too much, the classic sign is typically headaches when they stand up. And the reason behind that is when there's overdrainage, there's less cerebrospinal fluid in their ventricular system, which means less intracranial pressure. So that when they stand up, the pressure differential between their head and the ground is more than when they're lying down. And because of that pressure differential, they usually have worsening headaches when standing up or sitting up. The other thing are severe headaches, which would be a sign of a subdural hematoma or focality in their neurological symptoms that could point to a subdural hematoma, such as weakness, numbness, speaking problems, depending on the hemisphere. How we work this up is, regardless if you're concerned about overdrainage or underdrainage, we usually start with a CAT scan or an MRI scan. Typically, we prefer a CAT scan because it's quicker, but the CAT scan will show us if the ventricular caliber is the same and/or the placement of the proximal catheter. So, what we look for when we see that CAT scan or that MRI to see the location of the proximal catheter to make sure it hasn't changed from any previous settings. And then we see the caliber of the ventricles. If the caliber of the ventricles is smaller, that could be a sign of overdrainage. If the caliber of the ventricles are larger, it could be a sign of underdrainage. The other thing we look for are subdural fluid collections or hydromas or subdural hematomas, which would be another sign of lower endocranial pressure, which would be a sign of overdrainage. So those are the biggest signs we look for, for underdrainage and overdrainage. Other things we can look for if we're concerned of the shunt is fractured, we do a shunt X-ray and what a shunt x-ray is is x-rays of the skull, the neck and the abdomen to see the catheter to make sure it's not kinked or fractured. If you're really concerned, you can't tell from the x-ray, another scan to order is a CT of the chest and abdomen and pelvis to look at the location of the catheter to make sure there's no brakes in the catheter, there's no fluid collections on the distal portion of the catheter, which would be a sign of shunt malfunction as well. Other tests that you can do to really exclude shunt malfunction is a shunt patency test, and what that is a nuclear medicine test where radionucleotide is injected into the valve and then the radionucleotide is traced over time or imaged through time to make sure that it's draining appropriately from the valve into the distal catheter into the peritoneum or the distal site. If there's a shunt malfunction that's not drainage, that radioisotope would remain stagnant either in the valve or in the catheter. There's overdrainage, we can't really tell, but there will be a quick drainage of the radioisotope. For shunt infection, we start with an imaging just to make sure there's not a shunt malfunction, and that usually requires cerebrospinal fluid to test. The cerebrospinal fluid can come from the valve itself, or it can come from other areas like the lumbar spine. If the lumbar spine is showing signs of shunt infection, then that usually means the shunt is infected. If the valve is aspirated with- at the bedside with a butterfly needle into the valve and that shows signs of shunt infection, that also could be a sign of infection. Dr Berkowitz: That's very helpful. You mentioned CT and shunt series. One question that often comes up when obtaining neuroimaging in patients with a shunt, who have NPH or otherwise, is whether we need to call you when we're doing an MRI to reprogram the shunt before or after. Is there a way we can know as a neurologists at the bedside or as patients carry a card, like with some devices where we know whether we have to call and bother our neurosurgery colleagues to get this MRI? Or if the radiology techs ask us, is this safe? And is the patient's shunt going to get turned off? How do we go about determining this? Dr Chaichana: Yeah, so unfortunately, a lot of patients don't carry a card. We typically offer a card when we do the shunt, but that card, there's two problems with it. One is it tells the model, but the second thing is it has to be updated any time the shunt is changed to a different setting. Oftentimes patients don't know that shunt setting, and often times they don't know that company brand that they use. There are different types of shunts with different types of settings. If there's ever concern as to what type of shunt they have, an x-ray is usually the best bet to see with a shunt series, or a skull x-ray. A lateral skull x-ray usually looks at the valve, and the valve has certain radio-dense markers that indicate what type of shunt it is. And that way you can call neurosurgery and we can always tell you what the shunt setting is before the MRI is done. Problem with an MRI scan if you do it without a shunt x-ray before is that you don't know the setting before unless the patient really knows or it's in the patient chart, and the MRI can need to change the setting. It doesn't usually turn it off, but it would change the setting, which would change the fluid dynamics within their ventricular system, which could lead to overdrainage or underdrainage. So, any time a patient needs MRI imaging, whether it's even the brain MRI, a spine MRI, or even abdominal MRI, really a shunt x-ray should be done just to see the shunt setting so that it could be returned to that setting after the MRI is done. Dr Berkowitz: So, the only way to know sort of what type of shunt it would be short of the patient knowing or the patient getting care at the same hospital where the shunt was placed and looking it up in the operative reports would be a skull film. That would then tell us what type of shunt is there and then the marking of the setting. And then we would be able to call our colleagues in neurosurgery and say, this patient is getting an MRI this is the setting, this is the type of shunt. And do we need to call you afterwards to come by and reprogram it? Is that right? Dr Chaichana: That's correct, yeah. Dr Berkowitz: Is there anything we would be able to see on there, or it's best we just- best we just call you and clarify? Dr Chaichana: The easiest thing to do is, when you get the skull x-ray, you can Google different types of shunts or search for different shunts, and they'll have markers that show the type of shunt it is as well as the setting that it's at. And just match it up with the picture. Dr Berkowitz: And as long as it's not a programmable shunt, there's no concern about doing the MRI. Is that right? Dr Chaichana: Correct. So, if it's a programmable shunt, even if it's MRI-compatible, we still like to get the setting before and make sure the setting after the MRI is the same. Nonprogrammable shunts can't be changed with MRI scans, and those don't need neurosurgery after the MRI scan, but it should be confirmed before the scan is done. Dr Berkowitz: Very helpful. Okay, so let's turn to NPH specifically. As you know, there's a lot of debate in the literature, some arguing, even, NPH might not even exist, some saying it's underdiagnosed. I think. I don't know if it was last year at our American Academy of Neurology conference or certainly in recent years, there was a pro and con debate of “we are underdiagnosing NPH” versus “we are overdiagnosing NPH.” What's your perspective as a neurosurgeon? What's the perspective in neurosurgery? Is this something we're underdiagnosing, and the times you shunt these patients you see miraculous results? Is this something that we're overdiagnosing, you get a lot of patients sent to that you think maybe won't benefit from a shunt? Or is it just really hard to say and some patients have shunt-responsive noncommunicating hydrocephalus of unclear etiology and either concurrent Parkinson's disease, Alzheimer's, cervical lumbar stenosis, neuropathy, vestibular problems, and all these other issues that play into multifactorial gait to sort of display a certain amount of the percentage of problem in a given patient or take overtime? What's your perspective if you're open to sharing it, or what's the perspective of neurosurgery? Is this debated as it is in neurology or this is just a standard thing you see and patients respond to shunt to some degree in some proportion of the time? And what are the sort of predictors you see in your experience? Dr Chaichana: Yeah, so, for me, I'd say it's too complicated for a neurosurgeon to evaluate. We rely on neurology to tell us whether or not they need a shunt. But I think the problem is, obviously, a part of the workout for at least the ones that I like to do, is that I want them to have a high-volume lumbar puncture with pre- and postgait analysis to see if there's really an objective measure of them improving. If they have an objective measure of improvement---and what's even better is that they have a subjective measure of improvement on top of the objective measure of improvement---then they benefit from a shunt. The problem is, some patients do benefit even though they don't have objective performance increases after a high-volume shunt. And those are the ones that make me the most worrisome to do the shunt, just because I don't like to do a procedure where there's no benefit for the patient. I do see, according to the literature as well, that there's around a 30 to 40%, even 50%, increase in gait function, even in patients that don't have large improvements following the high-volume lumbar puncture. And those are the most challenging patients for us as neurosurgeons because we'll put the shunt in, they say we're no better in terms of their gait, no better in terms of their urinary incontinence. We try to lower their shunt down to a certain setting and we're kind of stuck after that point. The good thing about NPH, though, is that, from the neurosurgery side, the shunt, like I said, is a pretty benign, low-risk procedure. So, we're not putting the patient through a very severe procedure to see if there's any benefit. So, in cases where we try to improve their quality of life in patients that don't have a benefit from high-volume lumbar puncture, we give them the odds of whether or not it's improving and say it might not improve. But because the procedure's minimally invasive, I think it's a good way to see if we can benefit their quality of life. Dr Berkowitz: Yeah, it's a very helpful perspective. Yeah, those are the most challenging cases on our side as well, right. If the patient- we think they may have NPH, or their gait and/or urinary and/or cognitive problems are- at least have a component of NPH that could be reversible, we certainly want to do the large volume lumbar puncture and/or consider a lumbar drain trial, all discussed in other articles and interviews for this issue of Continuum, But the really tough ones, as you said, there is this literature on patients who don't respond to the large-volume lumbar puncture for some reason but still may be shunt responsive. And despite all the imaging predictors and all the other ways we try to think about this, it's hard to know who's going to benefit. I think that's really a helpful perspective from your end that, as you say in the very beginning of your article, right, maybe there's a little bit too much fear of shunting on the neurology side because when we hear about shunts, it's often in the setting of complication. And so, we're not sort of getting the full spectrum of all the patients you shunt and you see who are doing just fine. They might not improve---the question is related to NPH---but at least they're not harmed by the shunt, and we're maybe overbiased and/or seeing a overly representative sample of negative shunt outcomes when they're actually not that common in practice. Is that a fair summary of your perspective? Dr Chaichana: Yeah, that's correct. So, I mean, complications can occur---and anytime you do a surgery, there are risks of complications---but I think they're relatively low for the benefit that we can help their quality of life. And the procedure's pretty short. So, the risk, it mostly outweighs the benefits in cases with normal pressure hydrocephalus. Dr Berkowitz: Very helpful perspective. So, well, thanks so much again. Today I've been interviewing Dr Kaisorn Chaichana about his article on management of normal pressure hydrocephalus, which he wrote with Dr Jeremy Cutsforth-Gregory. This article appears in the most recent issue of Continuum on disorders of CSF dynamics. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining us today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

The Co-Main Event MMA Podcast
Episode 654: Saying goodbye to Cool Dusty P

The Co-Main Event MMA Podcast

Play Episode Listen Later Jul 15, 2025 62:53


Dustin Poirier's last fight is this weekend. You know, allegedly. All relevant disclaimers apply. Still, if anyone deserves to ride off into the sunset with his legacy intact and his chin held high, it's Cool Dusty P. Call it cliché if you want, but they really don't make them like him anymore. On this episode: hear our discussion of his upcoming third fight against Max Holloway this weekend at UFC 318. Plus, Derrick Lewis out here: Throwing. Them. Bungalows. And how did we know someone would correctly identify the CME as the MMA show to ask about Conor McGregor's dick pic? Learn more about your ad choices. Visit megaphone.fm/adchoices

Thinking Crypto Interviews & News
THE FED, FDIC, & OCC GIVE BANKS ABILITY TO PUMP CRYPTO!

Thinking Crypto Interviews & News

Play Episode Listen Later Jul 15, 2025 18:59


Gastrointestinal Cancer Update
HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Gastrointestinal Cancer Update

Play Episode Listen Later Jul 15, 2025 88:55


Dr Haley Ellis from Massachusetts General Hospital in Boston, Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Dr Sara Lonardi from the Veneto Institute of Oncology IOV-IRCCS in Padua, Italy, and Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discuss patient cases and provide their perspectives on clinical datasets informing the care of patients with HER2-positive gastrointestinal cancer.  CME information and select publications here.

Gastrointestinal Cancer Update
HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Gastrointestinal Cancer Update

Play Episode Listen Later Jul 15, 2025 88:55


Dr Haley Ellis from Massachusetts General Hospital in Boston, Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Dr Sara Lonardi from the Veneto Institute of Oncology IOV-IRCCS in Padua, Italy, and Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discuss patient cases and provide their perspectives on clinical datasets informing the care of patients with HER2-positive gastrointestinal cancer.  CME information and select publications here.

CCO Oncology Podcast
Experts Discuss CELMoDs in Myeloma

CCO Oncology Podcast

Play Episode Listen Later Jul 15, 2025 35:51


In this episode, Jesus Berdeja, MD; Amrita Krishnan, MD, FACP; and Sagar Lonial, MD, FACP, discuss key topics with CELMoD therapy for multiple myeloma, including: Mechanistic differences between CELMoDs and IMiDsEmerging data with CELMoDs and their potential therapeutic roles across the disease continuum of multiple myelomaThe clinical implications of MRD negativity as a surrogate marker of long-term outcomes in clinical trials in multiple myelomaPresenters:Jesus Berdeja, MDDirector of Myeloma ResearchGreco-Hainsworth Centers for ResearchTennessee OncologyNashville, TennesseeAmrita Krishnan, MD, FACPDirector, Judy and Bernard Briskin Center for MyelomaExecutive Director of HematologyCity of Hope Orange CountyProfessor of Hematology/HCTCity of Hope Cancer CenterIrvine, CaliforniaSagar Lonial, MD, FACPChair and ProfessorDepartment of Hematology and Medical OncologyAnne and Bernard Gray Family Chair in CancerChief Medical OfficerWinship Cancer InstituteEmory UniversityAtlanta, GeorgiaContent based on an online CME program supported by an independent educational grant from Bristol Myers Squibb.Link to full program: https://bit.ly/3IwbslQ

Life Coaching for Women Physicians
269: The Anti-Aging Power of Resistance Training

Life Coaching for Women Physicians

Play Episode Listen Later Jul 14, 2025 17:05


Dr. Novitsky's message is clear:“It's never too late to start strength training."Whether you're in your 30s or 70s, building muscle and improving strength is one of the best things you can do for your body and mind."In this inspiring episode, obesity medicine expert, Ali Novitsky MD, MD dives deep into the transformative power of strength training, especially its profound benefits for anti-aging, longevity, and overall health. With a special focus on individuals aged 70 and older, Dr. Novitsky shares why now is the perfect time to begin — or restart — your strength journey, no matter your age or fitness level.

Bowel Sounds: The Pediatric GI Podcast
Bowel Sounds Summer School - Eosinophilic Esophagitis

Bowel Sounds: The Pediatric GI Podcast

Play Episode Listen Later Jul 14, 2025 34:08


In this episode of Bowel Sounds Summer School, hosts Drs. Jennifer Lee and Peter Lu have taken highlights from past episodes on eosinophilic esophagitis (EoE) and put them into a special episode jam-packed with clinical pearls. Former expert guests Dr. Glenn Furuta, Dr. Amanda Muir, Dr. Rachel Chevalier, and Dr. Mike Wilsey explain how to diagnose, treat, and monitor patients with EoE.Our Bowel Sounds Summer School series will include 4 episodes each summer on big topics in our field, artisanally crafted for the ears of listeners of all stages from the young student to the seasoned attending.Learning ObjectivesReview clinical presentation and diagnostic criteria for eosinophilic esophagitis (EoE)Review dietary and medication treatment options for EoE Review methods of monitoring treatment response in EoEFeatured EpisodesGlenn Furuta - Eosinophilic EsophagitisAmanda Muir - Navigating the Challenges of Eosinophilic Esophagitis ManagementRachel Chevalier - Update on Topical Steroids for EoEMike Wilsey - Esophageal Strictures in ChildrenSupport the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Research To Practice | Oncology Videos
HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Research To Practice | Oncology Videos

Play Episode Listen Later Jul 14, 2025 88:55


Featuring perspectives from Dr Haley Ellis, Dr Sara Lonardi and Dr Kanwal Raghav, moderated by Dr Christopher Lieu, including the following topics: Introduction (0:00) Gastroesophageal Cancers — Dr Lonardi (1:54) Biliary Tract Cancers — Dr Ellis (39:20) Colorectal Cancer — Dr Raghav (1:07:10) CME information and select publications

Addiction Medicine Journal Club
62. Naltrexone Pills vs Injections for Alcohol Use Disorder

Addiction Medicine Journal Club

Play Episode Listen Later Jul 14, 2025 36:14


In episode 62 we discuss the article “Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients with Alcohol Use Disorder.” Magane KM, et al.Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 1;185(6):635-645. We also discuss reduced overdose deaths and changes in buprenorphine labelling to include higher doses. NPR:Drug deaths plummet among young Americans as fentanyl carnage eases Federal Register:Modifications to Labeling of Buprenorphine-Containing Transmucosal Products for the Treatment of Opioid Dependence --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go tothis link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visitMI CARES. CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music:composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer:Dr. Patrick Beeman A podcast fromArs Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. Learn more about your ad choices. Visit megaphone.fm/adchoices

Practical EMS
110 | Michelle Niemeyer | The art of bending time | Learning to be in the moment | Burnout | What is keeping you from being fulfilled?

Practical EMS

Play Episode Listen Later Jul 13, 2025 34:34


Creator of the philosophy The Art of Bending TimeYou can find her work at Michelleniemeyer.com, LinkedIn and can text CLARITY to 33777 to get supportMichelle talks about a turning point in her life where she ended up in the ER and how this changed her perspective on health and nutrition after she was later diagnosed with PBCIs burnout in our control?Michelle says that the things that cause burnout are not in our control, but you can impact how you respond and how you look at the worldShe recommends focusing on the things that you enjoy in your day, meditating on themMichelle talks about some of the struggles she had as a lawyer and how it was difficult to not see the benefit of her work for 8 months to a year sometimesLearn to be in the moment, if you are thinking about the future all the time you will suffer anxiety and if you are thinking about the past, you will be depressedSetting goals is important, you need to be working towards something in life and figure out an action plan to accomplish themMake sure they are goals that YOU want, as opposed to something that someone else wants for youDelegate certain tasks, ask for help, don't always micromanageStep back and allow others to learn and growMichelle talks about how shifting from running all the time to enjoying walks outside improved her health and prevented injuryShe talks about the importance of getting enough sleep and movementNutrition can be medicineMichelle talks about a big case she was working on and how some dedicated, focused time, away from distractions, with adequate rest and movement, helped her throughTake care of yourself before you take care of patients To get focused work done, you need to set up your environment correctly and remove distractionsOne distraction can make you lose precious focus one a given taskMultitasking is a mythBurnout happens when people don't feel any meaning in what they're doingSometimes switching jobs or careers will not solve burnout, but establishing some good habits can recreate the fulfillment in your current job againYou don't see the light when you stay doing the same stuffSupport the showFull show notes can be found here: Episodes - Practical EMS - Content for EMTs, PAs, ParamedicsMost efficient online EKG course here: Practical EKG Interpretation - Practical EMS earn 4 CME and learn the fundamentals through advanced EKG interpretation in under 4 hours. If you want to work on your nutrition, increase your energy, improve your physical and mental health, I highly recommend 1st Phorm. Check them out here so they know I sent you. 1st Phorm | The Foundation of High Performance Nutrition Everything you hear today from myself and my guests is opinion only and doesn't represent any organizations or companies that any of us are affiliated with. The stories you hear have been modified to protect patient privacy and any resemblance to real individuals is coincidental. This is for educational and entertainment purposes only and should not be taken as medical advice nor used to diagnose any medical or healthcare conditions.

Prostate Cancer Update
Urothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Prostate Cancer Update

Play Episode Listen Later Jul 11, 2025 60:11


Dr Matthew D Galsky from The Tisch Cancer Institute in New York, New York, Prof Andrea Necchi from the IRCCS San Raffaele Hospital in Milan, Italy, and Prof Thomas Powles from the Barts Cancer Institute in London provide their perspectives on clinical scenarios and datasets informing the care of patients with urothelial bladder cancer. CME information and select publications here.

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast
Jacob Sands, MD - Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast

Play Episode Listen Later Jul 11, 2025 17:53


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XDB865. CME credit will be available until June 26, 2026.Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.

Market Trends with Tracy
Beef Prices Finally Blink

Market Trends with Tracy

Play Episode Listen Later Jul 11, 2025 3:21


Beef: Beef prices are finally starting to cool after the July 4th holiday – but how fast will they fall, and which cuts will drop first? With low production still keeping things tight, we're not in freefall territory yet… but if you're buying ribeyes, strips, or grinds, you'll want to hear what's coming next.Poultry: Chicken remains the go-to protein, with wings in tight supply and prices climbing again. Breasts and tenders are steady for now – but with hot summer temps affecting animal intake and a new avian flu case on the radar, will this balanced market stay steady... or tip?Grains: Prices are down across corn, soy, and wheat, but with crops thriving in the fields and new tariffs shaking up export dynamics, how long will this calm last?Pork: Bacon lovers, brace yourselves—bellies are climbing and could hit $200 soon. But beyond bacon? The rest of the pork market is cooling off… for now.Dairy: A calm week on the dairy front—but is it the quiet before a dip? With butter holding steady and cheese prices barely budging, the market might just be gearing up for a slide.Savalfoods.com | Find us on Social Media: Instagram, Facebook, YouTube, Twitter, LinkedIn

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
Jacob Sands, MD - Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Play Episode Listen Later Jul 11, 2025 19:42


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XDB865. CME credit will be available until June 26, 2026.Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.

Experts InSight
Private Equity Acquisition and Access to Retinal Detachment Surgery

Experts InSight

Play Episode Listen Later Jul 10, 2025 29:05


Drs. Durga Borkar and Yashaswini Singh join host Dr. Jay Sridhar to discuss their recent publication regarding private equity (PE) acquisition and access to retinal detachment surgery. According to the study, physicians in PE-acquired practices decreased their number of retinal detachment repairs by nearly 20% after acquisition, potentially negatively impacting access to care and patient outcomes. Discussed in today's podcast: Singh Y, Cardenas GB, Torabzadeh H, Whaley CM, Borkar D. Private Equity-Owned Physician Practices Decreased Access To Retinal Detachment Surgery, 2014-22. Health Affairs. 2025 May;44(5):589-596. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Research To Practice | Oncology Videos
Urothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Research To Practice | Oncology Videos

Play Episode Listen Later Jul 10, 2025 60:12


Featuring perspectives from Dr Matthew D Galsky, Prof Andrea Necchi and Prof Thomas Powles, moderated by Dr Galsky, including the following topics: Introduction (0:00) Current and Future Management of Muscle-Invasive Bladder Cancer — Prof Powles (1:14) Novel Intravesical Therapies Under Evaluation for Nonmetastatic Urothelial Bladder Cancer (UBC) — Prof Necchi (24:48) Selection and Sequencing of Therapy for Metastatic UBC — Dr Galsky (44:52) CME information and select publications

Hematologic Oncology Update
Non-Hodgkin Lymphoma — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Hematologic Oncology Update

Play Episode Listen Later Jul 10, 2025 119:42


Dr Jeremy Abramson from Massachusetts General Hospital in Boston, Dr Joshua Brody from the Tisch Cancer Institute in New York, New York, Dr Christopher Flowers from The University of Texas MD Anderson Cancer Center in Houston, Dr Ann LaCasce from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Tycel Phillips from City of Hope Comprehensive Cancer Center in Duarte, California, discuss patient cases and provide their perspectives on clinical datasets informing the care of patients with non-Hodgkin lymphoma. CME information and select publications here.

The Lumber Word
EP 129: The Price Is (Already) Right?

The Lumber Word

Play Episode Listen Later Jul 10, 2025 43:21


Bart Charles returns, and we're not mad about it. This week, we unpack the buzz around Hem-Fir now being deliverable on the CME lumber contract—try to stay with us, it's worth it. Gregg walks through what's happening in the cash markets and how deep the inventory buying goes. Then we all weigh in on how much of the upcoming CVD/AD action is already priced in. As usual, we gave away more trading insight than we should've… but if you're listening, we figure you earned it. Contact the show members at: Charles@AtlanticForest.Com Gregg@Sitkainc.com Ashley@Sitkainc.com

The Doctor’s Crossing Carpe Diem Podcast
Episode #224: Get Started With An Employed Role in Integrative and Functional Medicine

The Doctor’s Crossing Carpe Diem Podcast

Play Episode Listen Later Jul 9, 2025 36:52


Have you ever dreamed of working in a more holistic, patient-centered way—without having to start your own practice from scratch? If so, you're going to love today's episode. We're diving into the growing field of integrative and functional medicine—especially for those who want the stability of an employed role while practicing in a more meaningful, whole-person way. In this episode, I'm joined by Lisa McDonald, founder of Integrative Connections, a leading job board and recruiting service for integrative and functional medicine. Lisa is not a physician, but her own healing journey through functional medicine inspired her to help others find their way into this meaningful field. She shares what these roles really look like and how to find your path into one. Whether you're just starting to explore this field or wondering what kind of training might be helpful, Lisa offers practical tips, personal stories, and lots of encouragement for taking that first step—or simply testing the waters. You can find the show notes for this episode and more information by clicking here: www.doctorscrossing.com/episode224 In this episode we're talking about: What is integrative and functional medicine? Why are more physicians seeking to incorporate these modalities into how they care for patients? What kinds of patients and conditions do these practices typically see? The training and certifications that can increase your knowledge and help you stand out Typical visit length, scheduling, and expectations in integrative jobs How to explore these roles and ask the right questions in interviews Advice for physicians curious about pivoting into integrative or functional care Links for this episode: https://integratedconnects.com https://integratedconnects.com/professional-development/ https://www.linkedin.com/in/lisapmcdonald/ Andrew Weil Center For Integrative Medicine - 2-year fellowship with several onsite weeks in AZ https://awcim.arizona.edu/education/fellowship Institute for Functional Medicine - can be fully remote, but also in-person conferences. Free 1.5 hour CME course https://ifm.org Episode #23: Curious About Integrative and Functional Medicine? Carpe Diem Resume Kit - Converting your CV to a resume helps recruiters better understand why you are a great match for a specific job. My resume kit will guide you through creating a polished resume for your desired job. Templates are included as well as a bonus on writing your cover letter. Reach out to us at team@doctorscrossing.com for more information!

Crain's Daily Gist
07/10/25: Sales surge for Chicago's most premium homes

Crain's Daily Gist

Play Episode Listen Later Jul 9, 2025 50:47


Crain's residential real estate reporter Dennis Rodkin and host Amy Guth discuss the latest news from the local market, including record-breaking sales in Chicago's higher housing tier and Cook County's push for affordable modular homes.Plus: Office demand freefall resumes as downtown vacancy reaches a new record high, Rivian's micro-EV spinoff valued at $1 billion, Blue Cross parent renames Medicare offerings following Cigna deal and CME debates the meaning of "trading floor" as $2 billion trial gets underway.

Research To Practice | Oncology Videos
Non-Hodgkin Lymphoma — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Research To Practice | Oncology Videos

Play Episode Listen Later Jul 9, 2025 119:43


Featuring perspectives from Dr Jeremy S Abramson, Dr Joshua Brody, Dr Christopher Flowers, Dr Ann LaCasce and Dr Tycel Phillips, moderated by Dr Abramson, including the following topics: Introduction (0:00) Selection and Sequencing of Available Therapies for Diffuse Large B-Cell Lymphoma — Dr Flowers (2:24) Evolving Management Paradigm for Mantle Cell Lymphoma — Dr Phillips (31:53) Integration of Novel Therapies into the Management of Follicular Lymphoma — Dr LaCasce (54:51) Integrating Bispecific Antibodies into the Management of Non-Hodgkin Lymphoma (NHL) — Dr Brody (1:11:22) Current Role of CAR T-Cell Therapy in Various NHL Subtypes — Dr Abramson (1:37:55) CME information and select publications